{
    "2019-06-05": [
        [
            {
                "time": "2019-05-01",
                "original_text": "财丰风险指北月报：2019年5月“爆雷”机构及产品分析",
                "features": {
                    "keywords": [
                        "风险",
                        "爆雷",
                        "机构",
                        "产品"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-01",
                "original_text": "药明康德(02359.HK)遭摩根大通减持169.66万股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "摩根大通",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-01",
                "original_text": "医药行业政策点评:医改任务清单落地,改革进入深水区",
                "features": {
                    "keywords": [
                        "医药",
                        "政策",
                        "医改",
                        "深水区"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-01",
                "original_text": "2019年6月医药行业投资策略:行业数据逐渐回暖,政策推动结构分化",
                "features": {
                    "keywords": [
                        "医药",
                        "投资策略",
                        "行业数据",
                        "回暖",
                        "政策",
                        "结构分化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}